Holen Sie sich die Stockscreener-App
6.81
3.50%
0.23
Schlusskurs vom Vortag:
$6.58
Offen:
$6.54
24-Stunden-Volumen:
40,252
Relative Volume:
0.11
Marktkapitalisierung:
$217.12M
Einnahmen:
$1.22M
Nettoeinkommen (Verlust:
$-22.43M
KGV:
-5.889
EPS:
-1.1564
Netto-Cashflow:
$-18.78M
1W Leistung:
+1.34%
1M Leistung:
+817.67%
6M Leistung:
+1,198%
1J Leistung:
+810.31%
1-Tages-Spanne:
$6.53
$6.88
1-Wochen-Bereich:
$6.51
$7.299
52-Wochen-Spanne:
$0.475
$7.299
Longeveron Inc Stock (LGVN) Company Profile
Firmenname
Longeveron Inc
Sektor
Branche
Telefon
305-302-7158
Adresse
1951 NW 7TH AVENUE, MIAMI
Compare LGVN vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LGVN
Longeveron Inc
|
6.81 | 26.40M | 1.22M | -22.43M | -18.78M | -1.1564 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Longeveron Inc Stock (LGVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-06 | Eingeleitet | ROTH MKM | Buy |
Longeveron Inc Aktie (LGVN) Neueste Nachrichten
Longeveron (NASDAQ: LGVN) insider logs new stock trades - Stock Titan
Longeveron (LGVN) grants director 36,000 stock units - Stock Titan
Longeveron (NASDAQ: LGVN) insider reports new stock dealings - Stock Titan
Longeveron (LGVN) Q2 2026 Earnings Call Transcript - AOL.ca
Longeveron (LGVN) Earnings Reading: Profit Per Share Falls Below Its Benchmark at the Close; After Results: The Stock Gains 4.46% in the Current UpdateProfitability Analysis - vinanet.vn
Longeveron appoints Nirav Jhaveri as chief financial officer - Investing.com Nigeria
Longeveron Appoints Nirav Jhaveri as CFO Ahead of September Trial Data - Minichart
symbol__ Stock Quote Price and Forecast - CNN
Longeveron CFO Marie Washburn to switch roles, Nirav Jhaveri to succeed - TipRanks
Longeveron Appoints New Chief Financial Officer Jhaveri - TipRanks
Longeveron Appoints Nirav Jhaveri As CFO - marketscreener.com
Longeveron appoints Nirav Jhaveri as chief financial officer By Investing.com - Investing.com India
Longeveron Inc. Appoints Nirav Jhaveri as Chief Financial Officer - Quiver Quantitative
Longeveron Appoints Nirav Jhaveri as Chief Financial Officer - Yahoo Finance
Marie Washburn Net Worth (2026) - GuruFocus
Longeveron reports Q2 EPS (19c) vs. (33c) last year - TipRanks
$Longeveron (LGVN.US)$ - Moomoo
LGVN Stock Slips After Hours As FDA Flags Concerns On Rare Heart Defect Trial Design - Stocktwits
Longeveron Stock Price Forecast. Should You Buy LGVN? - StockInvest.us
Longeveron Inc. (LGVN) investors disclose 9% beneficial stake through warrant holdings - Stock Titan
Longeveron LLC earnings missed by $0.01, revenue fell short of estimates - Investing.com Nigeria
Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update - BioSpace
Longeveron Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Longeveron Q2 EPS $(0.19) Misses Estimate, Sales Fall 9% - scanx.trade
LGVN: Q2 2026 net loss rose to $6.1M as HLHS trial data and XPRIZE finalist status drive near-term focus - TradingView
Earnings call transcript: Longeveron misses Q2 2026 estimates as cash runs tight - Investing.com
Longeveron Inc. (LGVN) Q2 FY2026 earnings call transcript - Yahoo Finance
Longeveron Reports $6.1 Million Q2 Net Loss Ahead Of ELPIS II Data - Quiver Quantitative
Longeveron Q2 net loss widens on higher legal, clinical trial costs - TradingView
LGVN: Q2 2026 net loss rose 22% as clinical and legal expenses increased ahead of key trial results - TradingView
BRIEF-Longeveron Q2 EPS USD -0.19 - TradingView
Longeveron Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Longeveron (LGVN) Rises 7.92% to $0.75, Approaches Key Resistance at $0.79Retracement Entry - vinanet.vn
Earnings To Watch: Longeveron Inc (LGVN) Q2 2026 -- GF Value Sees 58% Downside - Yahoo Finance
Longeveron Selected as XPRIZE Healthspan Milestone 2 Awardee for Laromestrocel Clinical Trial Results - Quiver Quantitative
Longeveron Named a Finalist Team and Will Receive a - GlobeNewswire
LGVN Q1 2026 Earnings: Wider-than-Expected Loss Reflects Pipeline InvestmentEarnings Surprise Report - vinanet.vn
Longeveron Inc. (LGVN): Millennium group discloses 5.2% Class A equity stake - Stock Titan
Longeveron Restores Nasdaq Compliance with New Audit Committee - TipRanks
Earnings Preview: Longeveron to Report Financial Results Post-market on August 12 - Moomoo
LGVN Q2'26 Earnings: revenue estimate is 326.00K USD - TradingView
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Longeveron Inc. of Class Action Lawsuit and Upcoming DeadlineLGVN - TMX Newsfile
Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026 - The Manila Times
Longeveron will share second-quarter results after markets close Aug. 12 - Stock Titan
Longeveron (LGVN) Surges 13.45% to $0.68: Clinical-Stage Biotech Tests Key ResistanceIchimoku TK Cross - Vinanet
Longeveron (NASDAQ: LGVN) refreshes audit committee with four independent directors - Stock Titan
Longeveron Inc. Revenue Breakdown – NASDAQ:LGVN - TradingView
Longeveron Inc (LGVN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Longeveron Inc (LGVN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Longeveron Inc (LGVN) Cash Flow - TradingKey
Longeveron Inc (LGVN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Finanzdaten der Longeveron Inc-Aktie (LGVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.86%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):